Eli Health Raises $3.6 Million To Improve Women’s Health With Saliva-Based Continuous Hormone-Monitoring Technology

Hormone fluctuations affect a broad range of conditions, transitions, and symptoms experienced by women from puberty to post-menopause. These fluctuations impact not only menstrual cycles but also various aspects of women’s physical and mental health. Apart from being related to reproductive health – menopause, fertility, and contraception, hormones are behind endocrine conditions, which means that hormones impact much […]

These 3 Women Are Shaping The Future Of Women’s Health By Bringing Next Generation Of Femtech Products To The Market

It’s not a secret that finally, after years of being overlooked, women’s health is having its moment. According to Frost & Sullivan’s report, the femtech (female technology) market revenue is expected to reach $1.1 billion by 2024, growing at a compound annual growth rate (CAGR) of 12.9%. The report states that, through solutions targeting early diagnosis and leveraging […]

Eli Raises $1.9 Million CAD in Seed Funding to Develop At-Home Hormone Monitoring Tech

Eli Science Inc. has raised a $1.9 million CAD ($1.5 million USD) seed round to target the historically underserved women’s healthtech market via its saliva-based daily hormone tracking technology. The round, which was co-led by Hong Kong’s Vectr Ventures and 2048 Ventures, closed in late December 2020. Other investors included Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and Steven Arless, who joined Eli […]

We Need Your Help graphic

Make your voice heard!

Sign our petition to urge the government to invest $100M in the Femtech Challenge for the 2025 Budget. Let’s reinforce Canada’s leadership in women’s health and advance gender equality.

Our website uses cookies to ensure you get the best experience. Learn More